The Stockholm stock exchange starts Thursday sideways. Moberg Pharma falls after the company confirmed study results.

After 31 minutes of trading, the OMXS30 index was down 0.01 percent to 2,595.33. During the day, the index has moved within the range -0.26 percent at its lowest and 0.15 percent at its highest.

The broad OMXSPI was down 0.10 percent.

Share pricePrice changeCommentary
Karolinska Development 7,8%Sells shares for almost SEK 40 million in Ossdsign to Linc
Medicover 5,6%Evaluating potential delisting of Indian subsidiary
Brinova 5,3%Buys properties from K-Fastigheter for SEK 10.8 billion
K-Fastigheter 2,0%Sells properties to Brinova for SEK 10.8 billion and becomes majority owner of Brinova
Astor 1,8%Pareto Securities initiates coverage with buy and target price SEK 12
Linc 1,5%Buys shares for almost SEK 40 million in Ossdsign from Karolinska Development
Inwido 1,0%Units in Scotland receive business worth SEK 300 million. Company reiterates long-term financial targets
Sweco 0,1%Takes order in Germany
Lundin Gold-1,0%Jefferies cuts to hold from buy, and lowers target price to 36 Canadian dollars from 37
AQ Group-1,2%Chairman has sold shares for SEK 82.9 million
Dustin-5,1%Kepler Cheuvreux lowers to hold from buy, lowers target price to SEK 4.70 from SEK 11
Moberg Pharma-40,6%Confirms that the results from the phase 3 study with MOB-015 in North America did not meet primary endpoints. Bayer Consumer Health stops upcoming launch